— Know what they know.
Not Investment Advice

UPB NASDAQ

Upstream Bio, Inc.
1W: -6.0% 1M: -22.2% 3M: -31.9% YTD: -80.7% 1Y: -70.9%
$5.04
+0.00 (+0.00%)
 
Weekly Expected Move ±6.0%
$4 $5 $5 $5 $6
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 30 · $274.3M mcap · 20M float · 3.04% daily turnover · Short 33% of daily vol

📊 Key Metrics

TTM
$3M
Revenue
+49.2% YoY
$-156M
Net Income
-76.9% YoY
$-136M
Free Cash Flow
-36.0% YoY
100.0%
Gross Margin
-5481.0%
Op. Margin
-5136.1%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-46.0%
ROA-44.6%
ROIC-1266.4%

Valuation

P/E-1.7
P/B1.0
EV/EBITDA-0.7

Leverage

Debt/Equity0.00
Current Ratio27.99
Interest Cov.0.0x

Quality Scores

Piotroski F3/9
Altman Z19.44
Beneish M-2.97

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms